Listed by the USPTO as TAKENAKA, RISA
Tech Center 1600 • Art Units: 1600 1632 1653 1682
This examiner grants 26% of resolved cases
TAKENAKA, RISA examines cases in tech center 1600 and art unit 1600. The profile contains 23 resolved cases, an allowance rate of 26.1%, and a median of 1429 days to allowance. The interview lift is 100.0%, so the recorded outcomes associate interviews with a substantial change in allowance results.
Wisconsin Alumni Research Foundation, Merck Sharp & Dohme LLC, and National Tsing Hua University appear among the leading companies. The listed firms are LEYDIG VOIT & MAYER, LTD, BIRCH STEWART KOLASCH & BIRCH, LLP, and Clark+Elbing LLP. The limited case volume calls for caution when using the percentages as a forecasting tool, while the median timing supports early attention to prosecution duration.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18613041 | REAGENTS AND METHODS FOR PROMOTING ARTERIAL ENDOTHELIUM DIFFERENTIATION AND NITRIC OXIDE PRODUCTION | Non-Final OA | Wisconsin Alumni Research Foundation |
| 17895068 | CELL IDENTIFICATION METHOD | Non-Final OA | National Tsing Hua University |
| 17611007 | NEURAL CELL POPULATION, NEURAL CELL-CONTAINING PREPARATION, AND METHOD FOR PRODUCING SAID POPULATION AND PREPARATION | Non-Final OA | UNIVERSITY OF TSUKUBA |
| 18339962 | ENGINEERED CYCLIC PEPTIDES FOR ENHANCING VIRAL PRODUCTION | Non-Final OA | Synvivia, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy26.1% of resolved applications examined by Risa Takenaka were allowed (23 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +100.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Risa Takenaka took 1,429 days on average from filing to allowance.
Risa Takenaka examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
